Long-Term Registries of Biologic Therapies May Determine Risk for Rare Adverse Events in JIA
Investigators compared long-term safety with regard to rare adverse events between various biologics to treat juvenile idiopathic arthritis.
Investigators compared long-term safety with regard to rare adverse events between various biologics to treat juvenile idiopathic arthritis.
Patients with early arthritis were classified by investigators according to specific rheumatoid arthritis autoantibodies.
Researchers assessed the prevalence and incidence rate of cardiovascular morbidity in patients with inflammatory arthritis and determined whether the coexistence of multiple autoimmune disorders was associated with increased risk for cardiovascular disease.
Researchers evaluated levels of serum anti-carbamylated protein antibodies and assessed their clinical value in systemic lupus erythematosus.
Researchers determined the effect of increased frequency of rehabilitation on stroke risk.
Researchers investigated the relationship between low back pain and falls among patients with knee osteoarthritis in a 12-month period.
Researchers aimed to characterize prevalence of Sjögren syndrome among children with recurrent parotitis.
In patients with type 2 diabetes, treatment with liraglutide does not affect bone resorption and preserves hip bone mineral density, even with weight loss.
Researchers compared the performance of 2 visual analog scale-based assessments, SSPGA and LFA-REAL, with outcome measures from other lupus trials.
In this study, researchers used immunophenotyping to explore the biomarkers associated with clinical characteristics in large vessel vasculitis.